Home Applications 206019 Application 206019
Type ANDA
Sponsor IPCA LABS LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE TABLET;ORAL EQ 25MG BASE No No 002 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE TABLET;ORAL EQ 50MG BASE No No 003 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE TABLET;ORAL EQ 100MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206019-001 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 A206019-002 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 A206019-003 SUMATRIPTAN SUCCINATE SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A206019-001 SUMATRIPTAN SUCCINATE EQ 25MG BASE TABLET / ORAL AB 2025-07-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A206019-002 SUMATRIPTAN SUCCINATE EQ 50MG BASE TABLET / ORAL AB 2025-07-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A206019-003 SUMATRIPTAN SUCCINATE EQ 100MG BASE TABLET / ORAL AB 2025-07-15 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 3 of 3 · 46 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.